e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury
A. Birukova, D. Burdette, P. Fu, K. Birukov (Chicago, United States Of America)
Source:
Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Session:
Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury
Session type:
E-Communication Session
Number:
418
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Birukova, D. Burdette, P. Fu, K. Birukov (Chicago, United States Of America). PKA- and Epac/Rap-dependent mechanisms of lung endothelial barrier protection in acute lung injury. Eur Respir J 2009; 34: Suppl. 53, 418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
CXCL5-dependent neutrophil recruitment harms lung barrier function in acute lung injury
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Endothelial- but not leukocytic-NOX2 mediates vascular injury in ischemia/reperfusion syndrome of the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 822s
Year: 2006
The role of pendrin in acute lung injury caused by ventilator-induced lung injury
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury
Source: Eur Respir J 2013; 41: 165-176
Year: 2013
Endothelial barrier function during lung injury
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Iloprost protects against lung endothelial barrier dysfunction and vascular leak via Rap1
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009
Mechanisms of acute lung injury
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Induction of antioxidant defense mechanisms by amifostine in lung tissue attenuates ventilator induced lung injury
Source: Annual Congress 2010 - New insights into reactive oxygen species
Year: 2010
Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury in lung transplantation
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004
Desferrioxamine attenuates minor lung injury following surgical acute liver failure
Source: Eur Respir J 2009; 33: 1429-1436
Year: 2009
Impaired leukocyte kinetics in pulmonary microvessels of ventilator-induced lung injury
Source: Eur Respir J 2001; 18: Suppl. 33, 196s
Year: 2001
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Effect of prior statin therapy on capillary permeability in the lungs after cardiac or vascular surgery
Source: Eur Respir J 2006; 27: 1026-1032
Year: 2006
IL-9 protects against bleomycin-induced lethal lung injury through a prostaglandin-dependent mechanism
Source: Eur Respir J 2004; 24: Suppl. 48, 105s
Year: 2004
Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury
Source: Eur Respir J, 53 (3) 1800786; 10.1183/13993003.00786-2018
Year: 2019
Cellular recruitment mechanisms following lung injury
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Vaporized perfluorocarbon confers protection against acute lung injury by inhibiting MMP-9 expression without protective effects in other organs
Source: Annual Congress 2010 - Acute respiratory failure
Year: 2010
Buffering of the acidosis induced by hypercapnia modulates the inflammatory process in lung and distal organs in experimental acute lung injury
Source: Annual Congress 2009 - Acute lung injury: biological mechanisms
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept